Fosun Pharma: Net profit for 2025 is approximately 3.371 billion yuan, an increase of 21.69% year-on-year.

NightAirdropper · 2026-03-27T11:01:17+00:00

Fosun Pharma releases annual performance report, expecting 2025 revenue of 41.662 billion yuan, a year-on-year increase of 1.45%; net profit attributable to parent company of 3.371 billion yuan, a year-on-year increase of 21.69%; basic earnings per share of 1.27 yuan, a year-on-year increase of 22.12%.

NightAirdropper

2026-03-27 11:01:17

Abstract generation in progress

Everyday AI News reports that Fosun Pharma (SH 600196, closing price: 24.31 yuan) released its annual performance report on the evening of March 24, stating that the operating revenue for 2025 is approximately 41.662 billion yuan, an increase of 1.45% year-on-year; the net profit attributable to shareholders of the listed company is approximately 3.371 billion yuan, an increase of 21.69% year-on-year; and the basic earnings per share is 1.27 yuan, an increase of 22.12% year-on-year.

Everyday Headlines (nbdtoutiao) - Investigating the wildly speculated AI “Lobster Course”: selling for as high as 18,999 yuan, moms and senior citizens are eager to learn, but the ones making money are not the students.

Disclaimer: The content and data in this article are for reference only and do not constitute investment advice. Please verify before use. Any actions taken based on this are at your own risk.

Daily Economic News

View Original

This page may contain third-party content, which is provided for information purposes only (not representations/warranties) and should not be considered as an endorsement of its views by Gate, nor as financial or professional advice. See Disclaimer for details.

1 Likes